Technology

Kindred Biosciences

$4.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-1.00%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell KIN and other stocks, options, and ETFs commission-free!

About KIN

Kindred Biosciences, Inc. Common Stock, also called Kindred Biosciences, is a development-stage biopharmaceutical company, which focuses on saving and improving the lives of pets. The company was founded by Richard Chin and Denise M. Bevers on September 25, 2012 and is headquartered in Burlingame, CA. The listed name for KIN is Kindred Biosciences, Inc. Common Stock.

CEO
Richard H. Chin
Employees
156
Headquarters
Burlingame, California
Founded
2012
Market Cap
189.41M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
264.24K
High Today
$5.06
Low Today
$4.75
Open Price
$4.99
Volume
262.31K
52 Week High
$11.93
52 Week Low
$3.11

Collections

KIN Earnings

-$0.45
-$0.10
$0.25
$0.60
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, After Hours

You May Also Like

ASHR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure